Literature DB >> 9874511

Modulation of bone morphogenetic protein-2 and bone morphogenetic protein-4 gene expression in osteoblastic cell lines.

A S Virdi1, L J Cook, R O Oreffo, J T Triffitt.   

Abstract

Bone morphogenetic proteins (BMPs) belong to the transforming growth factor-beta (TGF-beta) superfamily and are crucial factors in the process of bone formation. Despite knowledge on their wide distribution and expression, however, there is very little information on the biological factors that affect gene transcription of these osteoinductive agents. To investigate this aspect of BMP gene regulation we have studied the effect of a number of factors known to affect osteogenic cells. Northern analysis showed modulation of the expression of BMP-2 and BMP-4 mRNAs in two human osteosarcoma cell lines, MG63 and Saos-2, by prostaglandin E2 (PGE2), interleukin-1beta (IL-1beta), interleukin-6 (IL-6), interferon-alpha (IFN-alpha), retinoic acid and 1,25(OH)2 vitamin D3. mRNA expressions of the normally used "housekeeping genes", glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and beta-actin, were found to be susceptible to influence by some of the factors used. Hence, an oligo(dT)15-18 probe was used to reliably estimate the relative quantities of mRNA present for normalization of data. In general, all factors down-regulated mRNA expressions of BMP-2 and BMP-4 in MG63 cells. IL-6 completely abolished detectable expression of BMP-2 mRNA, which was also greatly reduced by IL-1beta, retinoic acid and 1,25(OH)2 vitamin D3. PGE2 had similar influences on BMP-2 and BMP-4 expressions, showing reductions to approximately 60% of normal. In Saos-2 cells only 1,25(OH)2 vitamin D3 had any great effect on BMP-2 expression, which was down-regulated to approximately 60% of control values. BMP-4 was down-regulated by IFN-alpha (approximately 60%) and IL-1beta (approximately 20%). We conclude that BMPs are subject to regulation by a variety of factors and that this is dependent on the stage of the cell in the osteogenic lineage. Furthermore, the use of GAPDH and beta-actin genes as "housekeeping genes" in expression-modulation studies must be treated with care.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9874511

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  12 in total

1.  Changes in gene expression in response to polyamine depletion indicates selective stabilization of mRNAs.

Authors:  I Veress; S Haghighi; A Pulkka; A Pajunen
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

2.  CYR61 regulates BMP-2-dependent osteoblast differentiation through the {alpha}v{beta}3 integrin/integrin-linked kinase/ERK pathway.

Authors:  Jen-Liang Su; Jean Chiou; Chih-Hsin Tang; Ming Zhao; Chun-Hao Tsai; Pai-Sheng Chen; Yi-Wen Chang; Ming-Hsien Chien; Chu-Ying Peng; Michael Hsiao; Ming-Liang Kuo; Men-Luh Yen
Journal:  J Biol Chem       Date:  2010-07-30       Impact factor: 5.157

3.  The zinc finger transcription factor Gli2 mediates bone morphogenetic protein 2 expression in osteoblasts in response to hedgehog signaling.

Authors:  Ming Zhao; Mei Qiao; Stephen E Harris; Di Chen; Babatunde O Oyajobi; Gregory R Mundy
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

4.  Retinoic acids potentiate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells.

Authors:  Wenli Zhang; Zhong-Liang Deng; Liang Chen; Guo-Wei Zuo; Qing Luo; Qiong Shi; Bing-Qiang Zhang; Eric R Wagner; Farbod Rastegar; Stephanie H Kim; Wei Jiang; Jikun Shen; Enyi Huang; Yanhong Gao; Jian-Li Gao; Jian-Zhong Zhou; Jinyong Luo; Jiayi Huang; Xiaoji Luo; Yang Bi; Yuxi Su; Ke Yang; Hao Liu; Hue H Luu; Rex C Haydon; Tong-Chuan He; Bai-Cheng He
Journal:  PLoS One       Date:  2010-07-30       Impact factor: 3.240

5.  Endogenous bone morphogenetic proteins mediate 1alpha, 25-dihydroxyvitamin D(3)-induced expression of osteoblast differentiation markers in human dermal fibroblasts.

Authors:  Christopher K Hee; Steven B Nicoll
Journal:  J Orthop Res       Date:  2009-02       Impact factor: 3.494

Review 6.  Bone and mineral disorders in pre-dialysis CKD.

Authors:  Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

Review 7.  Nonclassical aspects of differential vitamin D receptor activation: implications for survival in patients with chronic kidney disease.

Authors:  Dennis Andress
Journal:  Drugs       Date:  2007       Impact factor: 9.546

8.  Molecular analysis of enthesopathy in a mouse model of hypophosphatemic rickets.

Authors:  Eva S Liu; Janaina S Martins; Wanlin Zhang; Marie B Demay
Journal:  Development       Date:  2018-08-10       Impact factor: 6.868

9.  Comparative analysis of zebrafish bone morphogenetic proteins 2, 4 and 16: molecular and evolutionary perspectives.

Authors:  Cátia L Marques; Ignacio Fernández; Michael N Viegas; Cymon J Cox; Paulo Martel; Joana Rosa; M Leonor Cancela; Vincent Laizé
Journal:  Cell Mol Life Sci       Date:  2015-09-04       Impact factor: 9.261

10.  Oral paricalcitol for the treatment of secondary hyperparathyroidism in chronic kidney disease.

Authors:  Steven Cheng; Daniel Coyne
Journal:  Ther Clin Risk Manag       Date:  2006-09       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.